Breaking News Instant updates and real-time market news.

BX

Blackstone

$35.91

(0.00%)

, TEAM

Atlassian

$111.23

(0.00%)

09:40
04/18/19
04/18
09:40
04/18/19
09:40

Unusually active option classes on open April 18th

Unusual total active option classes on open include: Blackstone (BX), Atlassian (TEAM), SPDR Euro STOXX (FEZ), American Express (AXP), Alcoa (AA), Schlumberger (SLB), Constellation Brands (STZ), United Rentals (URI), Canopy Growth (CGC), and Health Care Sector SPDR ETF (XLV).

BX

Blackstone

$35.91

(0.00%)

TEAM

Atlassian

$111.23

(0.00%)

AXP

American Express

$111.78

(0.00%)

AA

Alcoa

$27.69

(0.00%)

SLB

Schlumberger

$47.39

(0.00%)

STZ

Constellation Brands

$191.63

(0.00%)

URI

United Rentals

$125.80

(0.00%)

CGC

Canopy Growth

$42.83

(0.00%)

XLV

Health Care Select Sector SPDR

$85.76

(0.00%)

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 24

    Apr

  • 06

    May

  • 07

    May

  • 08

    May

  • 14

    May

  • 17

    May

  • 18

    May

  • 05

    Jun

  • 05

    Jun

  • 11

    Jun

  • 13

    Nov

BX Blackstone
$35.91

(0.00%)

04/15/19
SBSH
04/15/19
UPGRADE
Target $35
SBSH
Neutral
Citi upgrades Franklin Resources, Artisan to Neutral from Sell
Citi analyst William Katz upgraded both Franklin Resources (BEN) and Artisan Partners (APAM) to Neutral from Sell. The analyst raised his price target to $35 from $28 for the former and to $25 from $20 for the latter. Ahead of the Q1 earnings season, however, the analyst favors the Alternatives. His top picks are Och-Ziff Capital (OZM), Brookfield (BAM) and Blackstone (BX). Katz, though, is "tactically less negative" on the Traditional asset managers.
09/25/18
ARGS
09/25/18
NO CHANGE
Target $46
ARGS
Buy
Blackstone price target raised to $46 from $39 at Argus
Argus analyst Stephen Biggar raised his price target on Blackstone to $46 and kept his Buy rating after its Investor Day presentation on Friday, citing the company's outlined plans to grow its assets under management to $1T from $439B currently. The analyst states that Blackstone is seeing "sees considerable growth in real estate, private equity, infrastructure, tactical opportunities and credit assets", adding that while the $1T target is "aggressive", it is also achievable, requiring "continuing cooperative economic environment and fundraising efforts". Biggar also anticipates Blackstone's "fee-related earnings component to grow significantly over the next two years" as its flagship funds reach key milestones, helping reduce earnings volatility and yielding "more consistent" dividend payouts.
11/30/18
MSCO
11/30/18
NO CHANGE
Target $42
MSCO
Overweight
Morgan Stanley more positive on Blackstone growth path after management meeting
After recently hosting an investor meeting with Jon Gray, Blackstone's President and COO, Morgan Stanley analyst Michael Cyprys said he is more positive on the company's growth trajectory, stating that its $130B fundraising pipeline should drive 50% growth in fee-related earnings over the next two years. The analyst, who also thinks a potential C-Corp conversion could unlock value in 2019, keeps an Overweight rating and $42 price target on Blackstone, adding that he thinks the shares could trade near $38 in the near-term if the market begins to assign higher odds to such a C-Corp change.
01/02/19
SUSQ
01/02/19
UPGRADE
Target $31
SUSQ
Positive
Crocs upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Sam Poser upgraded Crocs (CROX) to Positive from Neutral. The analyst cited the recent repurchase and conversion of Blackstone's (BX) preferred stock position as it removes a substantial financial overhang from the company's capital structure and shifts more control of the business into the hands of existing and potential shareholders. In addition, the business continues to accelerate as processes and products improve and the brand gains traction, said Poser, who raised his price target to $31 from $25 on Crocs shares.
TEAM Atlassian
$111.23

(0.00%)

04/18/19
MSCO
04/18/19
NO CHANGE
Target $99
MSCO
Underweight
Atlassian billings slowdown should make investors reassess, says Morgan Stanley
Morgan Stanley analyst Keith Weiss said he believes that Atlassian "truly is a great company" and "it's hard to be Underweight great companies," but leading into the company's earnings report he thought expectations appeared too high and coming out of the report he thinks the company's sharp deceleration in Q3 billings growth "likely forces investors to reassess the durable growth rate at Atlassian." Billings growth fell sharply to 31% year-over-year in Q3, noted Weiss, who sees "low thirties" as a more durable growth rate for Atlassian. He'd look to get more constructive if multiples better align to the trajectories of Atlassian's durable growth and margin expansion, said the analyst, who maintains an Underweight rating on the stock and raised his price target to $99 from $97.
04/18/19
BMOC
04/18/19
NO CHANGE
Target $110
BMOC
Market Perform
Atlassian price target raised to $110 from $100 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on Atlassian to $110, saying that while its Q3 result was not as "good as it looked", its guidance for Q4 was not as bad. The analyst cites the changes in pricing, which he says "meaningfully exacerbate seasonality of billings", also estimating the company's billings growth at an "impressive" 35%-40%. Bachman is keeping his Market Perform rating on Atlassian, noting that while the company offers a "compelling product suite" with "innovative pricing strategy", its current valuation does not offer a "favorable risk/reward."
04/18/19
COWN
04/18/19
NO CHANGE
Target $125
COWN
Outperform
Atlassian post-earnings pullback a buying opportunity, says Cowen
Cowen analyst J. Derrick Wood said that while Atlassian reported a mixed Q3, with a revenue beat and a billings miss, he would advise to take advantage of the pullback as "dips have historically been an opportune time to buy" the stock. Pull-forward activity in Q2 ahead of a mid-October price increase hurt deferred revenue growth and management said that this will impact Q4 deferred too, but to a lesser degree than Q3 and that the effect should fade each subsequent quarter, noted Wood. He maintains an Outperform rating on Atlassian with a $125 price target.
04/18/19
MZHO
04/18/19
NO CHANGE
Target $125
MZHO
Buy
Mizuho still comfortable buying Atlassian shares despite billings miss
Although Atlassian's fiscal Q3 revenue and earnings upside "was solid," billings were below consensus, Mizuho analyst Gregg Moskowitz tells investors in a post-earnings research note. However, his work indicates a "high likelihood" that this is solely a function of a greater than expected pull forward impact in fiscal Q2. Normalizing for this, the analyst estimates "very healthy" fiscal Q3 billings growth in the high 30% range. Moskowitz remains buying the shares, "especially on any significant weakness." He keeps a Buy rating on Atlassian with a $125 price target.
AXP American Express
$111.78

(0.00%)

04/01/19
COWN
04/01/19
NO CHANGE
COWN
FTC officials seem to spotlight Facebook, Amazon for scrutiny, says Cowen
After FTC Chairman Joe Simons and Competition Bureau Director Bruce Hoffman spoke at the American Bar Association's annual antitrust conference on Friday, Cowen analyst Paul Gallant said his read of some of Simons' comments on "consummated mergers" is that they seem directed toward Facebook (FB) deals like Instagram and Whatsapp and/or Google's (GOOGL) past ad tech acquisitions. Hoffman "also seemed to lean forward on tech," said Gallant, who sees some of Hoffman's comments on a prior ruling about American Express (AXP) as making Amazon (AMZN) more of an antitrust target than he expected. The analyst also noted that Sarah Oxenham-Allen, Chair of the State Attorney Generals Task Force on Antitrust, spoke at the event and he sees her comments as underscoring that state AGs are a "legitimate threat" on antitrust and privacy for Facebook and Google.
04/03/19
STFL
04/03/19
NO CHANGE
Target $85
STFL
Buy
Delta Air Lines price target raised to $85 from $80 at Stifel
Stifel analyst Joseph DeNardi raised his Q1 and 2019 EPS estimates for Delta (DAL) to reflect the company's revised Q1 guidance and increased his price target on the stock to $85 accordingly. Based on the company's comments on its new card deal with American Express (AXP), DeNardi believes Delta's economics from the pact improved by about 10% versus their prior agreement. He maintains a Buy rating on Delta shares.
04/02/19
SPHN
04/02/19
NO CHANGE
Target $63
SPHN
Overweight
Airlines needed some good news, and Delta delivered, says Stephens
With investor sentiment on the airline space negative, the group was in need of some good news and Delta Air Lines delivered a positive surprise this morning, Stephens analyst Jack Atkins tells investors in a research note. The airline pointed Q1 RASM growth to the upper-end of its initial guidance range, lowered its Q1 CASM excluding fuel expectation and raised its Q1 earnings guidance range, says the analyst. Atkins finds it encouraging that Delta noted underlying passenger demand remains solid and that the business market led the way during the quarter. Further, the company announced an extension of its credit card partnership with American Express (AXP), which is expected to double the revenue contribution to $7B by 2023 versus 2018 levels, he notes. Atkins reiterates an Overweight rating on Delta with a $63 price target. The stock in midday trading is up 7% to $55.64. Other names in the airline space include Alaska Air (ALK), American Airlines (AAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Continental (UAL).
03/20/19
DZBN
03/20/19
DOWNGRADE
DZBN
Hold
American Express downgraded to Hold from Buy at DZ Bank
AA Alcoa
$27.69

(0.00%)

04/18/19
JPMS
04/18/19
NO CHANGE
Target $52
JPMS
Overweight
Alcoa estimates and price target lowered at JPMorgan
JPMorgan analyst Michael Gambardella reduced his estimates for Alcoa to reflect lower earnings estimates for the company's Aluminum segment. However, Gambardella expects Alcoa's earnings to "take a step up" in the second half of 2019 and believes its efforts to improve operational performance and optimize its portfolio should continue to drive value this year and next. He lowered his price target for the shares to $52 from $60 but keeps an Overweight rating on the name. Gambardella does not see much further downside in alumina or aluminum prices, which he says creates an attractive risk/reward for Alcoa shares.
04/03/19
04/03/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Caterpillar (CAT) downgraded to Hold from Buy at Deutsche Bank with analyst Chad Dillard saying the biggest risk to the bull case for Caterpillar is if its backlog growth turns negative, "and it is becoming increasingly clear that it will within this next quarter." 2. Dunkin' Brands (DNKN) downgraded to Market Perform from Outperform at BMO Capital with analyst Andrew Strelzik saying that while he remains positive on the company's underlying fundamentals over the long term, he sees risk/reward at current levels as "less persuasive." 3. Tallgrass Energy (TGE) downgraded to Neutral from Buy at Goldman Sachs with analyst Michael Lapides citing the stock's recent outperformance and also warns that its Rockies Express Pipeline natural gas pipeline and Pony Express crude oil pipeline contract roll-offs pose "overhangs," even though the "volume growth out of Bakken, Niobrara, and Powder River Basin could offset this over time." 4. Walgreens Boots Alliance (WBA) downgraded to Hold from Buy at Loop Capital with analyst Andrew Wolf citing the company's disappointing Q2 earnings and FY19 guidance announced yesterday "driven by significantly lower-than-forecasted gross margin resulting from increased pharmacy reimbursement rate pressure in the U.S." 5. Alcoa (AA) downgraded to Neutral from Buy at BofA/Merrill with analyst Timna Tanners saying she now sees limited free cash flow payments by Alcoa to upstream AWAC joint-venture partner Alumina Ltd, potential excess alumina/bauxite supply, and potential price risks from the Alunorte refinery restarting, the world's largest refinery. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/03/19
BOFA
04/03/19
DOWNGRADE
BOFA
Neutral
Alcoa downgraded to Neutral from Buy at BofA/Merrill
04/03/19
04/03/19
DOWNGRADE
Target $31

Neutral
Alcoa downgraded to Neutral on lower prices at BofA/Merrill
As previously reported, BofA/Merrill downgraded Alcoa to Neutral from Buy and slashed its price target to $31 from $45. The global commodities team cut its aluminum price forecast by 5.4% for 2019 and 6.2% for 2020, for an average of $1,915/ton in 2019 and $1,900/ton in 2020, saying Chinese exports will cap potential price gains. Based on new forecasts, analyst Timna Tanners now sees limited free cash flow payments by Alcoa to upstream AWAC joint-venture partner Alumina Ltd, potential excess alumina/bauxite supply, and potential price risks from the Alunorte refinery restarting, the world's largest refinery.
SLB Schlumberger
$47.39

(0.00%)

03/15/19
JEFF
03/15/19
NO CHANGE
JEFF
Jefferies downgrades three, upgrades three in Oil Services & Equipment
Jefferies analyst Brad Handler made a handful of rating changes in Oil Services & Equipment. "The harder we look at OFS, the more modest the growth prospects seem," Handler tells investors in a research note. This supports a neutral sector view and favors stock picking, adds the analyst. He downgraded Schlumberger (SLB) to Hold from Buy following the stock's recovery as well as both Helmerich & Payne (HP) and Precision Drilling (PDS) to Hold from Buy on a flat U.S. rig count outlook. Handler also upgraded Oceaneering International (OII) to Buy from Hold citing more confidence in deepwater and a "reasonable" valuation, upgraded Keane Group (FRAC) to Buy from Hold on easing pricing pressure and optionality to put fleets back to work, and upgraded Superior Energy Services to Hold from Underperform. Handler's top picks are Baker Hughes (BHGE), Patterson-UTI (PTEN) and Keane Group. The latter two replace Helmerich & Payne and Apergy (APY).
03/10/19
GSCO
03/10/19
INITIATION
Target $55
GSCO
Buy
Schlumberger initiated with a Buy at Goldman Sachs
Goldman Sachs started Schlumberger with a Buy rating and $55 price target.
03/11/19
GSCO
03/11/19
INITIATION
GSCO
Goldman Sachs starts 19 in Oilfield Services, top pick is Baker Hughes
Goldman Sachs analyst Angie Sedita last night initiated coverage of 19 names in the Oilfield Services & Equipment space. The analyst sees three themes: A slow recovery in the offshore markers benefiting both offshore drilling and subsea, U.S. frac activity outpacing land drilling over the near-term, and a a surge of LNG projects moving forward benefiting companies exposed to those trends. Valuations are at the low end of historical ranges, says the analyst, who expects annual earnings growth of 15%-30% through 2021 for the group. Sedita's top pick is Baker Hughes (BHGE), a stock she started with a Conviction Buy rating. Her top Sell is Diamond Offshore (DO). Along with Baker Hughes, the analyst put Buy ratings on Halliburton (HAL), Schlumberger (SLB), Transocean (RIG), TechnipFMC (FTI), Nine Energy Services (NINE) and ProPetro Holding (PUMP). Along with Diamond Offshore, Sedita also put a Sell rating on RPC, Inc. (RES).
03/15/19
JEFF
03/15/19
DOWNGRADE
Target $45
JEFF
Hold
Schlumberger downgraded to Hold from Buy at Jefferies
Jefferies analyst Brad Handler downgraded Schlumberger to Hold from Buy and lowered his price target for the shares to $45 from $50.
STZ Constellation Brands
$191.63

(0.00%)

04/05/19
BMOC
04/05/19
NO CHANGE
Target $225
BMOC
Outperform
Constellation Brands wine/spirit divestment reshapes portfolio, says BMO Capital
BMO Capital analyst Amit Sharma kept his Outperform rating and $225 price target on Constellation Brands after the company announced a divestment of lower priced wine and spirits brands, saying the move "re-shapes" its portfolio and positions it on a "clear path" to double-digit core earnings growth. The analyst adds that Constellation Brands's FY20 outlook is likely conservative and believes it can generate "continued multiple recovery" from current levels, with added benefits coming from its "free call option" on Canopy.
04/05/19
MSCO
04/05/19
NO CHANGE
Target $230
MSCO
Overweight
Constellation Brands' FY20 guidance looks conservative, says Morgan Stanley
Morgan Stanley analyst Dara Mohsenian said he was surprised by the magnitude of the "relief rally" in Constellation Brands (STZ) shares following the company's Q4 report given that the company reported greater than expected near-term EPS dilution from its low-end wine sale, realized a lower than expected multiple on the wine transaction and unexpectedly did not provide forward guidance for Canopy Growth (CGC) equity losses. With that said, he sees "two clear positives" emerging from the quarter: the fact that fundamentals in the beer business remain solid and the fact that he sees solid visibility that Constellation can hit the high end of if $8.50-$8.80 FY20 EPS guidance, leaving aside Canopy equity losses. The analyst lowered his FY20 and FY21 EPS estimates to reflect dilution from the wine asset sale and trimmed his price target to $230 from $233, but he keeps an Overweight rating on Constellation shares.
04/05/19
BOFA
04/05/19
NO CHANGE
Target $216
BOFA
Buy
Constellation Brands price target raised to $216 from $188 at BofA/Merrill
BofA Merrill Lynch analyst Bryan Spillane raised his price target on Constellation Brands shares to $216 after the company reported better than expected Q4 earnings, stating that he believes a premium valuation is warranted by the company's higher than average EPS growth and margin improvement prospects. Spillane keeps a Buy rating on Constellation shares.
04/05/19
04/05/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Market Perform from Outperform at Wells Fargo with analyst Aaron Rakers saying the shares, after rallying 19% year-to-date, reflect a more balanced risk/reward. 2. Boston Beer (SAM) downgraded to Sell from Neutral at Goldman Sachs with analyst Judy Hong saying she sees headwinds in 2019 as competition intensifies and the company is "unlikely to repeat its innovation success again this year." 3. Ford (F) downgraded to Reduce from Neutral at Nomura Instinet with analyst Anindya Das saying Ford's higher share of the U.K. auto market compared to the rest of Europe makes it more susceptible to Brexit risks. 4. Constellation Brands (STZ) downgraded to Hold from Buy at Deutsche Bank. 5. International Paper (IP) downgraded to Sector Perform from Outperform at RBC Capital with analyst Paul Quinn saying while International Paper is a "great company," investors have increased scrutiny on the containerboard market due to the "softening demand and fears of incremental capacity coming online" as year-to-date shipment growth slowed to 0.8% from 1.5% in 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
URI United Rentals
$125.80

(0.00%)

02/19/19
STPT
02/19/19
DOWNGRADE
STPT
Hold
United Rentals downgraded to Hold from Buy at Standpoint Research
04/01/19
OTRG
04/01/19
DOWNGRADE
OTRG
Mixed
United Rentals downgraded to Mixed from Positive at OTR Global
OTR Global downgraded United Rentals to Mixed from Positive following checks that indicate flattening utilization and growth.
12/13/18
SBSH
12/13/18
NO CHANGE
SBSH
United Rentals added to the Citi Recommended List
Citi analyst Tobias Levkovich added United Rentals to the Citi Recommended List citing Tim Thein's Buy rating on the shares "due to a compelling positive fundamental outlook for the company and the US rental market into FY19."
12/14/18
LEHM
12/14/18
INITIATION
Target $130
LEHM
Equal Weight
United Rentals reinstated with an Equal Weight at Barclays
Barclays analyst Adam Seiden reinstated coverage of United Rentals with an Equal Weight rating and $130 price target. The analyst sees "slow, steady" low-to-mid single-digit growth for the rental industry in 2019, United Rentals included. He sees an even risk/reward at current share levels.
CGC Canopy Growth
$42.83

(0.00%)

04/12/19
PIPR
04/12/19
NO CHANGE
Target $60
PIPR
Overweight
Canopy Growth Q4 revenue estimate lowered at Piper Jaffray
Piper Jaffray analyst Michael Lavery trimmed his Q4 revenue estimates for Canopy Growth to reflect a more conservative build, based on early quarter Health Canada data. Based on April channel checks, product supply to retailers has recently improved, and stores are now maintaining some product inventory, Lavery tells investors in a research note However, Health Canada January industry data show industry momentum ramping up a bit more slowly than expected, adds the analyst. As such, Lavery lowered his Q4 revenue estimate for Canopy Growth to C$96.8M from C$117.6M. Capacity, scale and execution will continue to matter for the next 12-24 months, as growing supply catches up with strong demand in both Europe and Canada, says the analyst. He considers Canopy well positioned relative to its peers on these measures. Lavery keeps an Overweight rating on Canopy Growth shares with a $60 price target.
04/17/19
BOFA
04/17/19
INITIATION
Target $70
BOFA
Buy
Canopy Growth initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Christopher Carey initiated Canopy Growth (CGC) with a Buy and $70 price target saying it is positioned to be a long-term leader in the global cannabis sector. Carey said Canopy has scale with 6M square feet of cultivation capacity, capital following the Constellation (STZ) $4B investment, and vision as it lays groundwork to excel in areas higher on the value chain.
04/17/19
04/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Organogenesis (ORGO) initiated with an Outperform at Oppenheimer. 2. Teladoc (TDOC) initiated with an Overweight at Stephens. 3. Solar Capital (SLRC) initiated with an Outperform at Raymond James. 4. Principia Biopharma (PRNB) initiated with a Buy at Stifel. 5. Aurora Cannabis (ACB), HEXO Corp (HEXO), Canopy Growth (CGC), and Performance Food Group (PFGC) initiated with a Buy at BofA/Merrill while Cronos Group (CRON) was initiated with an Underperform at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/19
JEFF
04/18/19
NO CHANGE
JEFF
Hold
Canopy acquisition of Acreage would be 'big positive,' says Jefferies
Canopy Growth, according to reports last night, is set to acquire the rights to acquire one of the largest U.S. multi-state operators, Acreage Holdings, Jefferies analyst Owen Bennett tells investors in a research note. While details of the locked in purchase price are still not known, with Canopy sitting on C$4B of cash and the U.S. being the world's biggest market, this move is a "big positive," says Bennett. If Canopy were to wait to acquire a U.S operator post its listing requirements permitting, the price paid would be "way ahead of whatever has been agreed right now," he points out. Bennett has a Hold rating on Canopy Growth with a C$64 price target. The stock in premarket trading is up 7%, or $2.91, to $45.76.
XLV Health Care Select Sector SPDR
$85.76

(0.00%)

TODAY'S FREE FLY STORIES

QHC

Quorum Health

$0.95

0.0522 (5.81%)

17:31
12/06/19
12/06
17:31
12/06/19
17:31
Hot Stocks
Quorum Health receives NYSE continued listing standard notice »

Quorum Health Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:30
12/06/19
12/06
17:30
12/06/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXRX

Baudax Bio

$6.69

0.34 (5.35%)

17:29
12/06/19
12/06
17:29
12/06/19
17:29
Syndicate
Breaking Syndicate news story on Baudax Bio »

Baudax Bio files $125M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

LMT

Lockheed Martin

$387.10

1.175 (0.30%)

17:25
12/06/19
12/06
17:25
12/06/19
17:25
Hot Stocks
Lockheed Martin awarded $153.39M Navy contract modification »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$71.72

1.27 (1.80%)

17:23
12/06/19
12/06
17:23
12/06/19
17:23
Syndicate
Breaking Syndicate news story on Envestnet »

Envestnet files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$344.79

0.4 (0.12%)

17:20
12/06/19
12/06
17:20
12/06/19
17:20
Hot Stocks
Northrop Grumman awarded $189M Navy contract modification »

Northrop Grumman was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:03
12/06/19
12/06
17:03
12/06/19
17:03
Hot Stocks
Support.com announces special distribution of $1.00 per share »

The record date for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:01
12/06/19
12/06
17:01
12/06/19
17:01
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RZLT

Rezolute

$0.00

(0.00%)

17:00
12/06/19
12/06
17:00
12/06/19
17:00
Syndicate
Breaking Syndicate news story on Rezolute »

Rezolute files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,750.79

10.2 (0.59%)

16:58
12/06/19
12/06
16:58
12/06/19
16:58
Periodicals
U.S. mulls putting Amazon foreign sites on 'Notorious Markets' list, WSJ says »

The Trump administration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGTA

Magenta Therapeutics

$13.29

0.3 (2.31%)

16:55
12/06/19
12/06
16:55
12/06/19
16:55
Conference/Events
Magenta Therapeutics to hold an investor and analyst event »

Investor and Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

IMH

IMPAC Mortgage

$5.63

-0.01 (-0.18%)

16:54
12/06/19
12/06
16:54
12/06/19
16:54
Syndicate
Breaking Syndicate news story on IMPAC Mortgage »

IMPAC Mortgage files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.74

0.33 (1.70%)

16:32
12/06/19
12/06
16:32
12/06/19
16:32
Hot Stocks
Alector reports Phase 1 safety, biomaker data on AL002 »

Alector reported safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATAX

America First Multifamily Investors

$7.58

0.125 (1.68%)

16:31
12/06/19
12/06
16:31
12/06/19
16:31
Hot Stocks
America First Multifamily Investors CFO Craig Allen to retire »

On December 2,Craig Allen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
12/06/19
12/06
16:30
12/06/19
16:30
Options
Preliminary option volume of 20.4M today »

Preliminary option volume…

PNM

PNM Resources

$48.77

-0.06 (-0.12%)

16:29
12/06/19
12/06
16:29
12/06/19
16:29
Hot Stocks
PNM Resources raises quarterly dividend 6% to 30.75c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MORN

Morningstar

$154.47

-0.25 (-0.16%)

16:22
12/06/19
12/06
16:22
12/06/19
16:22
Hot Stocks
Morningstar raises quarterly dividend 7.1% to 30c from 28c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACEL

Alfacell Corporation

$11.11

0.1 (0.91%)

16:22
12/06/19
12/06
16:22
12/06/19
16:22
Hot Stocks
Crescent Park Management reports 6.4% passive stake in Accell »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$75.96

0.31 (0.41%)

16:21
12/06/19
12/06
16:21
12/06/19
16:21
Syndicate
Breaking Syndicate news story on Realty Income »

Realty Income files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/06/19
12/06
16:20
12/06/19
16:20
Options
Closing CBOE SPX and VIX Index summary for December 6th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

, BMY

Bristol-Myers

$59.94

0.435 (0.73%)

16:19
12/06/19
12/06
16:19
12/06/19
16:19
Hot Stocks
Bristol-Myers, Bluebird Bio: Phase 2 KarMMa study of ide-cel met endpoints »

Bristol-Myers Squibb…

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

BMY

Bristol-Myers

$59.94

0.435 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 11

    Dec

UBER

Uber

$27.87

-0.775 (-2.71%)

, ALXN

Alexion

$113.86

6.44 (6.00%)

16:18
12/06/19
12/06
16:18
12/06/19
16:18
On The Fly
Fly Intel: Wall Street's top stories for Friday »

For the first day in what…

UBER

Uber

$27.87

-0.775 (-2.71%)

ALXN

Alexion

$113.86

6.44 (6.00%)

MMM

3M

$171.43

7.07 (4.30%)

ICE

IntercontinentalExchange

$93.81

0.17 (0.18%)

TTD

Trade Desk

$247.63

7.36 (3.06%)

BIG

Big Lots

$25.22

6.05 (31.56%)

ULTA

Ulta Beauty

$262.19

26.1 (11.06%)

CIEN

Ciena

$35.01

-1.29 (-3.55%)

PD

PagerDuty

$21.81

-3.185 (-12.75%)

YEXT

Yext

$14.26

-2.355 (-14.17%)

ZM

Zoom Video

$62.76

-6.97 (-10.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 10

    Dec

  • 12

    Dec

  • 16

    Dec

  • 16

    Dec

  • 12

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
12/06/19
12/06
16:17
12/06/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLEX

Lilis Energy

$0.16

-0.0015 (-0.92%)

16:16
12/06/19
12/06
16:16
12/06/19
16:16
Hot Stocks
Lilis Energy discloses notice of NYSE listing deficiency »

Lilis Energ received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTRE

Watford Holdings

$26.49

0.34 (1.30%)

16:16
12/06/19
12/06
16:16
12/06/19
16:16
Hot Stocks
Watford Holdings to acquire Axeria IARD, terms not disclosed »

Watford Holdings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.